Insurer Seeks To Cover D&O Defenses In DMK Pharma Ch. 11

By Clara Geoghegan · July 3, 2024, 6:59 PM EDT

An insurance company asked a Delaware bankruptcy court Wednesday to let it pay defense expenses under a $5 million directors and officers policy for bankrupt biotechnology company DMK Pharmaceuticals Corp., which...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.

Case Number

24-10153

Judge

Mary F. Walrath

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$13.9M

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

DMK Pharmaceuticals Corporation

Case Number

24-10153

Court

Delaware

Nature of Suit

Date Filed

February 02, 2024

Recent Articles By Clara